The Center for Advancing Innovation is Currently Searching for Cancer Inventions and Portfolios
The Center For Advancing Innovation has run four startup challenges to date, launching approximately 58 startups from technologies licensed from the federal labs. CAI is focused on continuing this success with its fifth and largest challenge, the Freedom from Cancer Startup Challenge, to launch 100 startups by 2018 in the field of cancer. We have teamed up with the Laura and John Arnold Foundation and the large biotech giant MedImmune/AstraZeneca to accomplish this goal.
We are currently searching for inventors to submit inventions for consideration in this worldwide challenge. After reviewing the rules and additional criteria when submitting your invention, please do so on the form provided, below. Please fill in your invention(s) patent number as well as much of the additional criteria you are able. Note that these answers are not required, but would assist us in understanding your technologies.
Email Jonathan@thecenterforadvancinginnovation.org if you have any questions or would like to discuss your portfolio and the challenge further. Thank you.
Rules for Submitting Inventions
Additional Criteria for Inventions
The Challenge expects any third party inventions to at least have a valid proof-of-concept or be in a pre-IND stage in order to enter the challenge.
What is the potential end-user for the technology, e.g., head and neck cancer is most prevalent and has highest incidence in India, so a potential target patient population for head and neck cancer would be India
Novelty and Differentiation
Novelty is what makes this invention stand from a scientific and market standpoint. Why your invention is first of a kind/unique/different than what everyone else is doing/has done in the past.
What is the knowledge gap this invention fulfills (for example, current diagnostic/treatment can't address a certain patient group; has low response rate; is multi-drug resistant; current standard of care is costly, invasive, takes long time, etc.). Generally, unmet need indicates that a particular disease cannot be adequately treated
Financial viability is the degree to which this invention can make enough profit to offset R&D costs. Please consider time to market, patent life and market exclusivity timeframe extension possibilities such as an orphan indication. For example, a technology that will receive no market extensions must have 15 years of patent life if it's a therapeutic or vaccine type technology
Determine if the invention has any significant impediments to being developed, manufactured, and distributed. For example, consider what dependencies the technology has (required methodologies, equipment, legal, mortality, development, etc.); ability to recruit and retain patients in clinical trials; ease of manufacturing; stigmas associated with treatments, etc.